rivaroxaban oral suspension — Medica
Deep vein thrombosis or pulmonary embolism, reduction in risk of recurrence
Initial criteria
- If Xarelto tablets requested: approve
- If rivaroxaban oral suspension requested: patient is unable to have Xarelto tablets appropriately administered OR prescribed dose cannot be achieved by Xarelto 10 mg, 15 mg, or 20 mg tablets
Approval duration
1 year